# ANDA Submissions -- Refuse-to-Receive Standards Rev2 - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/anda-submissions-refuse-to-receive-standards-rev2/78b570c1-44d2-45b3-b780-47480621496b

> FDA guidance document: ANDA Submissions -- Refuse-to-Receive Standards Rev2. Issue date: December 28, 2016. Get complete insights and analysis.

---

## Details

- Title: ANDA Submissions -- Refuse-to-Receive Standards Rev2
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-12-28
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-1120">FDA-2013-D-1120</a>

## Related Documents

- [Determining Whether to Submit an ANDA or a 505(b)(2) Application](https://www.keypedia.com/guidances/guidance-document/determining-whether-to-submit-an-anda-or-a-505b2-application/c04d36f1-c78a-4aaf-8e45-6a99420cf632)
- [Botanical Drug Development: Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/botanical-drug-development-guidance-for-industry/bec78068-96c3-424e-b070-7b4ecfcfc8bf)
- [Nonprescription Sunscreen Drug Products – Format and Content of Data Submissions](https://www.keypedia.com/guidances/guidance-document/nonprescription-sunscreen-drug-products-format-and-content-of-data-submissions/4634e5dc-90b7-47fd-85c9-d7cbe6a199dc)